Franck’s Pharmacy Inc. has decided to voluntarily suspend all veterinary drug compounding pending the outcome of discussions with the Food and Drug Administration.

This latest move, announced Monday afternoon, is a sharp departure from the company’s earlier position. Just last month it vowed to defend an FDA request for an injunction that would prevent the Ocala-based pharmacy from compounding animal drugs using bulk ingredients that are not FDA-approved.

“Most of our customers will be unaffected by this change as we will continue to compound all human medicines,” Franck’s said in its Monday statement. “We are working with FDA to resolve this issue as quickly as possible to determine whether it will permit us to resume compounding of these important veterinary medicines.” Read more…